We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

STF-logo (1)
Bradley Canino

Bradley Canino

Director

Biotechnology, BioPharma

New York

[email protected] | (212) 271-3579 | v-Card | View Coverage
Brad Canino joined Stifel in 2021 as a Senior Analyst covering SMID cap biotechnology companies with a focus on precision oncology and medicines. Brad has equity research experience covering a diverse set of large- and small/mid-cap biopharma companies since 2015. Most recently, he was a senior analyst at Credit Suisse with a focus on oncology companies. Prior to his lead coverage role, he was a Vice President at SVB Leerink on its diversified biopharma research team. Brad began his career in biotechnology equity research at UBS, and he also has prior audit experience at PwC. He received a B.S. in Accounting and an MBA from Le Moyne College in Syracuse, NY.